Safer viruses for vaccine research and diagnosis

A new technology to produce safer ‘hybrid’ viruses at high volumes for use in vaccines and diagnostics for mosquito-borne diseases has been developed at The University of Queensland. Researchers from UQ and QIMR Berghofer Medical Research Institute have exploited the benign characteristics of the Binjari virus – inert to humans – to produce ‘dangerous looking’ … Read more Safer viruses for vaccine research and diagnosis

From the ‘valley of death’ to supply and demand sustainability – the unfinished agenda for immunisation

The best of science, entrepreneurship and politics is required to avoid ‘turning the clock back on immunisation’, argue a group of global health experts in a new Nature Review. Authored by scientists from the London School of Hygiene & Tropical Medicine (LSHTM), the World Health Organization (WHO), the Africa Centres for Disease Control and Prevention, … Read more From the ‘valley of death’ to supply and demand sustainability – the unfinished agenda for immunisation

Thermally-stable TB vaccine closer to reality thanks to microscopic silica cages

Scientists working on a new tuberculosis (TB) vaccine have achieved a major step forward by showing that a promising TB antigen and a novel vaccine adjuvant can be protected from heat damage with a technique developed at the University of Bath. Their method prevents these crucial vaccine components from spoiling outside of a fridge – … Read more Thermally-stable TB vaccine closer to reality thanks to microscopic silica cages

Measles vaccination: ‘All for one and one for all’

Measles was declared eradicated in the United States in 2000, but has reappeared in recent months in the form of outbreaks in several states. Of the 704 people in the U.S. infected with this highly contagious virus in 2019, 500 were never vaccinated and the remainder are likely to have never received a second follow … Read more Measles vaccination: ‘All for one and one for all’